|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 38247 |
FusionGeneSummary for TM9SF4_DEFB123 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: TM9SF4_DEFB123 | Fusion gene ID: 38247 | Hgene | Tgene | Gene symbol | TM9SF4 | DEFB123 | Gene ID | 9777 | 245936 |
| Gene name | transmembrane 9 superfamily member 4 | defensin beta 123 | |
| Synonyms | dJ836N17.2 | DEFB-23|DEFB23|ESC42-RELD | |
| Cytomap | 20q11.21 | 20q11.21 | |
| Type of gene | protein-coding | protein-coding | |
| Description | transmembrane 9 superfamily member 4dinucleotide oxidase disulfide thiol exchanger 3 superfamily member 4transmembrane 9 superfamily protein member 4tumor cannibalism associated protein 1 | beta-defensin 123beta defensin 23specific to testis and epididymis | |
| Modification date | 20180529 | 20180329 | |
| UniProtAcc | Q92544 | Q8N688 | |
| Ensembl transtripts involved in fusion gene | ENST00000398022, ENST00000217315, | ENST00000376309, | |
| Fusion gene scores | * DoF score | 14 X 13 X 8=1456 | 7 X 1 X 8=56 |
| # samples | 14 | 10 | |
| ** MAII score | log2(14/1456*10)=-3.37851162325373 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/56*10)=0.836501267717121 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: TM9SF4 [Title/Abstract] AND DEFB123 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | TM9SF4 | GO:0001666 | response to hypoxia | 25961573 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | UCS | TCGA-N8-A4PM-01A | TM9SF4 | chr20 | 30742989 | + | DEFB123 | chr20 | 30037832 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000398022 | ENST00000376309 | TM9SF4 | chr20 | 30742989 | + | DEFB123 | chr20 | 30037832 | + |
| Frame-shift | ENST00000217315 | ENST00000376309 | TM9SF4 | chr20 | 30742989 | + | DEFB123 | chr20 | 30037832 | + |
Top |
FusionProtFeatures for TM9SF4_DEFB123 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| TM9SF4 | DEFB123 |
| Associates with proteins harboring glycine-richtransmembrane domains and ensures their efficient localization tothe cell surface (PubMed:25999474). Regulates the assembly andactivity of V-ATPase in colon cancer cells via its interactionwith V-type proton ATPase subunit H (ATP6V1H) and contributes toV-ATPase-mediated pH alterations in cancer cells which play animportant role in drug resistance and invasiveness of colon cancercells (PubMed:25659576). Plays an important role in an atypicalphagocytic activity of metastatic melanoma cells calledcannibalism and is involved in the pH regulation of theintracellular vesicles in tumor cells (PubMed:19893578).{ECO:0000269|PubMed:19893578, ECO:0000269|PubMed:25659576,ECO:0000269|PubMed:25999474}. | Has antibacterial activity. {ECO:0000305}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for TM9SF4_DEFB123 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for TM9SF4_DEFB123 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| TM9SF4 | ELAVL1, IGF2R, SPCS2, TMX2, FAM162A, LAMP1, UQCRFS1, ATP1B3, F3, ERMP1, LMAN2, RAB1A, STX12, STX7, SGPL1, TMED2, CALD1, HIST1H1B, KDM5A, RPN2, S100A6, SLC25A12, OASL, RIOK3, H1FX, PHF14, ABCF2, SCAMP3, ATP5H, SACM1L, MKRN2, ITSN2, FCF1, SIRT6, TMEM161A, CDCA7L, ZC3H15, RPAP3, CEP44, RNF170, SP140L, H2AFV, ZNF800, NSMCE2, FAM3B, TSPAN11, TRIM25 | DEFB123 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for TM9SF4_DEFB123 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for TM9SF4_DEFB123 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|